Jeff Yass’s Dr. Reddy's Laboratories RDY Stock Holding History

Jeff Yass’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Buy	+19,000	New	+$256K	﹤0.01%	11241
2025 Q1	–	Sell	-33,200	Closed	-$524K	–	13290
2024 Q4	$524K	Buy	33,200 +4,200	+14%	+$63.1K	﹤0.01%	8548
2024 Q3	$461K	Buy	29,000 +6,000	+26%	+$96.5K	﹤0.01%	8654
2024 Q2	$350K	Buy	23,000 +1,000	+5%	+$14.3K	﹤0.01%	9114
2024 Q1	$323K	Buy	+22,000	New	+$321K	﹤0.01%	9549
2023 Q4	–	Sell	-53,500	Closed	-$716K	–	13145
2023 Q3	$716K	Buy	+53,500	New	+$724K	﹤0.01%	7393
2021 Q4	–	Sell	-18,500	Closed	-$241K	–	13764
2021 Q3	$241K	Sell	18,500 -74,000	-80%	-$986K	﹤0.01%	11091
2021 Q2	$1.36M	Buy	+92,500	New	+$1.29M	﹤0.01%	6920
2021 Q1	–	Sell	-25,500	Closed	-$364K	–	12747
2020 Q4	$364K	Sell	25,500 -21,000	-45%	-$283K	﹤0.01%	8904
2020 Q3	$647K	Buy	46,500 +2,000	+4%	+$23.8K	﹤0.01%	7126
2020 Q2	$472K	Sell	44,500 -15,000	-25%	-$153K	﹤0.01%	7480
2020 Q1	$480K	Buy	59,500 +31,500	+113%	+$263K	﹤0.01%	7029
2019 Q4	$227K	Sell	28,000 -24,000	-46%	-$190K	﹤0.01%	8537
2019 Q3	$394K	Buy	+52,000	New	+$387K	﹤0.01%	7769
2019 Q2	–	Sell	-42,500	Closed	-$344K	–	10727
2019 Q1	$344K	Sell	42,500 -30,500	-42%	-$232K	﹤0.01%	6984
2018 Q4	$550K	Sell	73,000 -18,000	-20%	-$127K	﹤0.01%	5840
2018 Q3	$630K	Buy	91,000 +35,000	+63%	+$234K	﹤0.01%	6111
2018 Q2	$361K	Buy	+56,000	New	+$353K	﹤0.01%	7476
2017 Q3	–	Sell	-65,000	Closed	-$548K	–	9484
2017 Q2	$548K	Buy	65,000 +8,000	+14%	+$65K	﹤0.01%	6477
2017 Q1	$458K	Buy	+57,000	New	+$492K	﹤0.01%	6645
2014 Q2	–	Sell	-87,500	Closed	-$768K	–	10038
2014 Q1	$768K	Buy	+87,500	New	+$761K	﹤0.01%	5989

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Jeff Yass's RDY Position: Q2 2026 in Review

Jeff Yass sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 42,300 shares — an estimated $571K sold.

Jeff Yass first reported a position in RDY in Q2 2013 and held it in 20 quarters. The position peaked at $2.79M in Q4 2015. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Jeff Yass reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
Jeff Yass sold 42,300 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $571K.
Jeff Yass first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 20 quarters.
Jeff Yass's Dr. Reddy's Laboratories position peaked at $2.79M in Q4 2015.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.